Historique
Bulletin de Périodique
Drug Testing and Analysis , Vol.8, n°1-2 - January-February 2016
Paru le :
01/02/2016
Année
2016
Page(s) :
1-261
Langue(s) :
Anglais
Note de contenu :
SELECTION :
- Annual banned-substance review: analytical approaches in human sports drug testing. Thevis M., Kuuranne T., Walpurgis K., Geyer H., Schänzer W., p. 7-29.
- Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC-HR-TOF-MS. Sundström M., Pelander A., Simojoki K., Ojanperä I., p. 39-45.
- Coronary thrombosis and marijuana smoking: a case report and narrative review of the literature. Marchetti D., Spagnolo A., De Matteis V., Filograna L., De Giovanni N., p. 56-62.
- The prevalence of new psychoactive substances in biological material - a three-year review of casework in Poland. Adamowicz P., Gieron J., Gil D., Lechowicz W., Skulska A., Tokarczyk B., p. 63-70.
- Test purchase, synthesis, and characterization of 2-methoxydiphenidine (MXP) and differentiation from its meta- and para-substituted isomers. McLaughlin G., Morris N., Kavanagh P.V., Power J.D., O'Brien J., Talbot B., et al., p. 98-109.
- Hair analysis for Delta9-tetrahydrocannabinolic acid A (THCA-A) and Delta9-tetrahydrocannabinol (THC) after handling cannabis plant material. Moosmann B., Roth N., Auwärter V., p. 128-132.
- Smoking habits of Italian athletes undergoing anti-doping control. Pacifici R., Pichini S., Palmi I., de la Torre X., Botrè F., the Anti-doping Commission at the Ministry of Health, p. 133-135.
- The use of presumptive color tests for new psychoactive substances. Cuypers E., Bonneure A.J., Tytgat J., p. 136-140.
- Cannabis: a self-medication drug for weight management? The never ending story. Bersani F.S., Santacroce R., Coviello M., Imperatori C., Francesconi M., Vicinanza R., et al., p. 177-179.
- Development of a high-speed MALDI-triple quadrupole mass spectrometric method for the determination of 3,4-methylenedioxymethamphetamine (MDMA) in oral fluid. Poetzsch M., Steuer A.E., Hysek C.M., Liechti M.E., Kraemer T., p. 235-240.
- In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS. Boumrah Y., Humbert L., Phanithavong M., Khimeche K., Dahmani A., Allorge D., p. 248-256.
- Annual banned-substance review: analytical approaches in human sports drug testing. Thevis M., Kuuranne T., Walpurgis K., Geyer H., Schänzer W., p. 7-29.
- Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC-HR-TOF-MS. Sundström M., Pelander A., Simojoki K., Ojanperä I., p. 39-45.
- Coronary thrombosis and marijuana smoking: a case report and narrative review of the literature. Marchetti D., Spagnolo A., De Matteis V., Filograna L., De Giovanni N., p. 56-62.
- The prevalence of new psychoactive substances in biological material - a three-year review of casework in Poland. Adamowicz P., Gieron J., Gil D., Lechowicz W., Skulska A., Tokarczyk B., p. 63-70.
- Test purchase, synthesis, and characterization of 2-methoxydiphenidine (MXP) and differentiation from its meta- and para-substituted isomers. McLaughlin G., Morris N., Kavanagh P.V., Power J.D., O'Brien J., Talbot B., et al., p. 98-109.
- Hair analysis for Delta9-tetrahydrocannabinolic acid A (THCA-A) and Delta9-tetrahydrocannabinol (THC) after handling cannabis plant material. Moosmann B., Roth N., Auwärter V., p. 128-132.
- Smoking habits of Italian athletes undergoing anti-doping control. Pacifici R., Pichini S., Palmi I., de la Torre X., Botrè F., the Anti-doping Commission at the Ministry of Health, p. 133-135.
- The use of presumptive color tests for new psychoactive substances. Cuypers E., Bonneure A.J., Tytgat J., p. 136-140.
- Cannabis: a self-medication drug for weight management? The never ending story. Bersani F.S., Santacroce R., Coviello M., Imperatori C., Francesconi M., Vicinanza R., et al., p. 177-179.
- Development of a high-speed MALDI-triple quadrupole mass spectrometric method for the determination of 3,4-methylenedioxymethamphetamine (MDMA) in oral fluid. Poetzsch M., Steuer A.E., Hysek C.M., Liechti M.E., Kraemer T., p. 235-240.
- In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS. Boumrah Y., Humbert L., Phanithavong M., Khimeche K., Dahmani A., Allorge D., p. 248-256.
Autre(s) lien(s) :
http://onlinelibrary.wiley.com/doi/10.1002/dta.v8.2/issuetoc
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
F. S. BERSANI ;
R. SANTACROCE ;
M. COVIELLO ;
C. IMPERATORI ;
M. FRANCESCONI ;
R. VICINANZA ;
A. MINICHINO ;
O. CORAZZA
|
2016
Dans Drug Testing and Analysis (Vol.8, n°1-2, January-February 2016) Article : Périodique
Dans Drug Testing and Analysis (Vol.8, n°1-2, January-February 2016) Article : Périodique
In a society highly focused on physical appearance, people are increasingly using the so-called performance and image-enhancing drugs (PIEDs) or life-style drugs as an easy way to control weight. Preliminary data from online sources (e.g. websit[...]